We are live on ! Find out more
AKYA

Akoya BioSciences
AKYA

Delisted

AKYA was delisted on the 7th of July, 2025.

Back to rankings

62 hedge funds and large institutions have $74.9M invested in Akoya BioSciences in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,371% more call options, than puts

Call options by funds: $173K | Put options by funds: $7K

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

1.26% less ownership

Funds ownership: 34.1% → 32.83% (-1.3%)

15% less funds holding

Funds holding: 73 → 62 (-11)

37% less capital invested

Capital invested by funds: $119M → $74.9M (-$43.8M)

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
62
Holders Change
-11
Holders Change %
-15.07%
% of All Funds
0.98%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
6
Increased
32
Reduced
12
Closed
17
Calls
$173K
Puts
$7K
Net Calls
+$166K
Net Calls Change
+$222K

Top Buyers

Rank Fund Capital Flow
1
KLC
Kent Lake Capital
Nevada
+$4.29M
2
BlackRock
BlackRock
New York
+$1.47M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$572K
4
Squarepoint
Squarepoint
New York
+$505K
5
PCH
Polar Capital Holdings
United Kingdom
+$369K

Top Sellers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
-$3.56M
2
PVI
Pura Vida Investments
New York
-$2.67M
3
CS
Candriam SCA
Luxembourg
-$2.04M
4
FAM
Fred Alger Management
New York
-$1.94M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
BWLSA
1
Blue Water Life Science Advisors
California
$21.8M – – –
PCH
2
Polar Capital Holdings
United Kingdom
$7.35M +$369K +64,286 +4%
BlackRock
3
BlackRock
New York
$6.72M +$1.47M +255,152 +21%
Vanguard Group
4
Vanguard Group
Pennsylvania
$6.28M +$237K +41,265 +3%
KLC
5
Kent Lake Capital
Nevada
$3.47M +$4.29M +746,521 New
BOTOTLSJU
6
Board of Trustees of The Leland Stanford Junior University
California
$2.89M – – –
UIC
7
Uniplan Investment Counsel
Wisconsin
$2.58M +$65.2K +11,344 +2%
Millennium Management
8
Millennium Management
New York
$2.52M +$206K +35,904 +7%
PHP
9
Parkman Healthcare Partners
Connecticut
$2.44M +$314K +54,623 +12%
SW
10
SVB Wealth
Massachusetts
$2.4M +$88.5K +15,400 +3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.17M +$572K +99,465 +27%
State Street
12
State Street
Massachusetts
$1.66M +$355K +61,833 +21%
RI
13
RTW Investments
New York
$1.57M – – –
KCM
14
Kennedy Capital Management
Missouri
$1.38M -$13K -2,259 -0.8%
Renaissance Technologies
15
Renaissance Technologies
New York
$989K +$191K +33,200 +19%
Northern Trust
16
Northern Trust
Illinois
$854K +$164K +28,552 +18%
Charles Schwab
17
Charles Schwab
California
$713K +$133K +23,132 +18%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$618K +$58.8K +10,233 +8%
SSA
19
Schonfeld Strategic Advisors
New York
$602K +$41.4K +7,200 +6%
Squarepoint
20
Squarepoint
New York
$592K +$505K +87,863 +223%
OCM
21
Osterweis Capital Management
California
$587K – – –
SI
22
Stephens Inc
Arkansas
$514K -$76.4K -13,299 -11%
Citadel Advisors
23
Citadel Advisors
Florida
$390K -$226K -39,283 -32%
WMSA
24
Weiss Multi-Strategy Advisers
New York
$279K -$16.3K -2,836 -5%
Goldman Sachs
25
Goldman Sachs
New York
$261K +$109K +18,949 New
1
2 3 4

AKYA Hedge Fund Activity: Q3 2023 in Review

62 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q3 2023, worth a combined $74.9M — down 37% from $119M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of AKYA and 6 opened new positions — a net loss of 11 holders — while 12 trimmed existing stakes and 32 added.

The largest buyer was Kent Lake Capital, opening a new position worth an estimated $4.29M. The largest seller was Granahan Investment Management, exiting entirely with an estimated $3.56M sold.

  • 62 institutional investors held Akoya BioSciences (AKYA) as of Q3 2023, down from 73 in Q2 2023.
  • Funds reported $74.9M of Akoya BioSciences stock for Q3 2023, down 37% quarter-over-quarter.
  • 6 funds opened new Akoya BioSciences positions in Q3 2023 and 17 closed out, a net change of -11 holders.
  • The largest Akoya BioSciences buyer in Q3 2023 was Kent Lake Capital, an estimated $4.29M added.
  • The largest Akoya BioSciences seller in Q3 2023 was Granahan Investment Management, an estimated $3.56M sold.

Based on aggregated 13F filings for Q3 2023.